CHICAGO (GenomeWeb) – At the intersection of genomics and proteomics, investigators are doing basic research bent on improving existing immunotherapies and better understanding response.

Attendees at the American Association for Cancer Research heard about just a few of these potential applications during a major symposium on cancer immunotherapy analyses here yesterday.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

23andMe's Anne Wojcicki ponders DNA and what it means to be human in a New York Times essay.

A new estimate places the last universal common ancestor to life on Earth as living 3.9 billion years ago, Inverse reports.

In PNAS this week: retinitis pigmentosa gene therapy, role of microbiome in growth stunting, and more.

Bloomberg reports that researchers and drug companies are modeling anti-obesity treatments after the rare genetic condition essential fructosuria.